Loading...
•
Jun 30, 2025
ICU Medical Q2 2025 Earnings Report
ICU Medical's Q2 2025 earnings showed a decrease in revenue but significant improvements in net income and adjusted diluted EPS compared to the prior year.
Key Takeaways
ICU Medical reported second quarter 2025 revenue of $548.9 million, a decrease from $596.5 million in the prior year. Despite the revenue decline, the company achieved a GAAP net income of $35.3 million, a substantial improvement from a net loss in Q2 2024. Adjusted diluted EPS also saw a notable increase to $2.10.
Second quarter 2025 revenue was $548.9 million, a decrease from $596.5 million in the same period last year.
GAAP net income for Q2 2025 was $35.3 million, a significant turnaround from a GAAP net loss of $(21.4) million in Q2 2024.
Adjusted diluted earnings per share increased to $2.10 in Q2 2025, up from $1.56 in Q2 2024.
Adjusted EBITDA for the second quarter of 2025 was $100.3 million, an increase from $91.3 million in the prior year period.
Revenue by Segment
Forward Guidance
For Fiscal Year 2025, ICU Medical updated its guidance, narrowing the range for GAAP net loss and adjusted EBITDA, while slightly increasing the lower end of the adjusted diluted earnings per share guidance.
Positive Outlook
- Adjusted diluted earnings per share guidance for FY2025 was updated to a range of $6.85 to $7.15, with the lower end increasing from previous guidance.
- The company's CEO stated that second quarter results were generally in line with expectations.
Challenges Ahead
- GAAP net loss guidance for FY2025 was updated to a range of $(43) million to $(35) million, indicating continued expected losses.
- GAAP diluted loss per share guidance for FY2025 was updated to a range of $(1.68) to $(1.38).
- Adjusted EBITDA guidance for FY2025 was narrowed to a range of $380 million to $390 million, with the upper end decreasing from previous guidance.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...